Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2019 - Google Patents
The present specification discloses a pharmaceutical composition comprising an active
agent that causes reduction of the level of systemic immunosuppression in an individual for …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2019 - Google Patents
(57) ABSTRACT A pharmaceutical composition comprising an active agent that causes
reduction of the level of systemic immunosup pression in an individual for use in treating a …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

M Eisenbach-Schwartz, K Baruch… - US Patent …, 2018 - Google Patents
A pharmaceutical composition comprising an active agent that causes reduction of the level
of systemic immunosuppression in an individual for use in treating a disease, disorder …

Treatment of T-cell mediated diseases

D Bar-Or, R Bar-Or, R Shimonkovitz - US Patent 7,732,403, 2010 - Google Patents
6,034,057 A 3/2000 Dutta............................ 514/9 JP O1013075 1, 1989 6,034,221 A 3, 2000
Berezenko et al. 530,362 JP 3176478 A2 7, 1991 6,060,452 A 5, 2000 Green et al. JP 05 …

Treatment of T-cell mediated diseases

D Bar-Or, R Bar-Or, R Shimonkevitz - US Patent 9,707,227, 2017 - Google Patents
(60) Provisional application No. 60/471,017, filed on May N 1 3.; 3. 15, 2003, provisional
application No. 60/489,270, filed on Jul. 21, 2003, provisional application No.(Continued) …

Treatment of t-cell mediated diseases

D Bar-Or, R Bar-Or, R Shimonkevitz - US Patent App. 13/679,599, 2013 - Google Patents
BACKGROUND 0003 T-cell mediated diseases represent a large number of immune system
disorders. In particular, T-cells are thought to be the cells that start and perpetuate …

Compositions and methods for modulating a cytotoxic T lymphocyte immune response

R Ruprecht, S Jiang - US Patent App. 11/022,562, 2005 - Google Patents
US20050249742A1 - Compositions and methods for modulating a cytotoxic T lymphocyte
immune response - Google Patents US20050249742A1 - Compositions and methods for …

Agent for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t cells

D Paulsen, N Brunner, D Bray - US Patent App. 12/941,885, 2011 - Google Patents
0001. This application is a continuation of copending International Patent Application
PCT/EP 2009/003076 filed on Apr. 28, 2009 and designating the United States, which was …